INSPHERO

InSphero AG develops organotypic biological 3D microtissues and microtissue-based assays for biochemical compounds screening and predictive drug testing applications. It offers human prostate and mammary carcinoma, and rat liver microtissues. The company also provides compound toxicity testing, cell-invasion assays, stem-cell research, cell-to-cell interaction, regenerative medicine, tissue engineering, and cell-to-extracellular matrix interaction services. In addition, it involves in study of t... ranscriptomics, proteomics, and metabolomics. Further, the company provides custom development services, which include microtissue development, H and E stained paraffin sections, growth characteristics data, and morphometric data. Its microtissue system enables the generation of various model systems using either tumor-derived cells to reconstitute primary tumors or primary cells to mimic structure and function of diverse organ tissues. InSphero AG was founded in 2009 and is based in Zurich, Switzerland.

#SimilarOrganizations #People #Financial #Website #More

INSPHERO

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Medical

Founded:

2009-01-01

Address:

Schlieren, Zurich, Switzerland

Country:

Switzerland

Website Url:

http://www.insphero.com

Total Employee:

11+

Status:

Active

Contact:

41 44 515 04 90

Email Addresses:

[email protected]

Total Funding:

35.18 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network